Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: "Acute Liver Failure in Children": Treatment and Directions for Future Research.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
3
5
2022
Statut:
ppublish
Résumé
The Hepatology Committee of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) aims to educate pediatric gastroenterologists, members of ESPGHAN and professionals from other specialties promoting an exchange of clinical expertise in the field of pediatric hepatology. The 2020 single topic ESPGHAN monothematic 3-day conference on pediatric liver disease, was organized in Athens, Greece and was entitled " Acute Liver Failure" (ALF). ALF is a devastating disease with high mortality and in a considerable fraction of patients, the cause remains unresolved. As knowledge in diagnosis and treatment of ALF in infants and children has increased in the past decades, the objective was to update physicians in the field with developments in medical therapy and indications for liver transplantation (LT) and to identify areas for future research in clinical and neurocognitive outcomes in ALF. We recently reported the epidemiology, diagnosis, and initial intensive care management issues in separate manuscript. Herewith we report on the medical treatment, clinical lessons arising from pediatric studies, nutritional and renal replacement therapy (RRT), indications and contraindications for LT, neurocognitive outcomes, new techniques used as bridging to LT, and areas for future research. Oral presentations by experts in various fields are summarized highlighting key learning points. The current report summarizes the current insights in medical treatment of pediatric ALF and the directions for future research.
Identifiants
pubmed: 35226644
doi: 10.1097/MPG.0000000000003345
pii: 00005176-202203000-00007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
338-347Informations de copyright
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Snehavardhan P, Lal BB, Sood V, et al. Efficacy and safety of sodium benzoate in the management of hyperammonemia in decompensated chronic liver disease of the childhood-a double-blind randomized controlled trial. J Pediatr Gastroenterol Nutr 2020; 70:165–170.
Squires RH, Dhawan A, Alonso E, et al. Pediatric Acute Liver Failure Study Group. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology 2013; 57:1542–1549.
Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract 2020; 35:30–35.
Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019; 38:485–521.
Schneeweiss B, Pammer J, Ratheiser K, et al. Energy metabolism in acute hepatic failure. Gastroenterology 1993; 105:1515–1521.
Walsh TS, Wigmore SJ, Hopton P, et al. Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 2000; 28:649–654.
Figuera E, Filho J, Nacif L, et al. Nutritional support for fulminant hepatitis. Nutricion Hospitalaria 2015; 32:2427–2432.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu ; Clinical practice guidelines panel, Wendon, J; Panelmembers. EASL Clinical Practical Guidelines on themanagement of acute (fulminant) liver failure. J Hepatol 2017;66:1047–81.
Berger MM, Reintam-Blaser A, Calder PC, et al. Monitoring nutrition in the ICU. Clin Nutr 2019; 38:584–593.
Devictor D, Tissieres P, Afanetti M, et al. Acute liver failure in children. Clin Res Hepatol Gastroenterol 2011; 35:430–437.
Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369:2525–2534.
Clemmesen JO, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000; 118:1131–1139.
Lutfi R, Abulebda K, Nitu ME, et al. Intensive care management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2017; 64:660–670.
Coss-Bu JA, Klish WJ, Walding D, et al. Energy metabolism, nitrogen balance, and substrate utilization in critically ill children. Am J Clin Nutr 2001; 74:664–669.
Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 2013; 58:325–336.
Dam G, Aamann L, Vistrup H, et al. The role of branched chain amino acids in the treatment of hepatic encephalopathy. J Clin Exp Hepatol 2018; 8:448–451.
Stravitz R, Kramer A, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the US acute liver failure study group. Crit Care Med 2007; 35:2498–2508.
Fivez T, Kerklaan D, Mesotten D, et al. Early versus late parenteral nutrition in critically ill children. N Engl J Med 2016; 374:1111–1122.
Deep A, Stewart CE, Dhawan A, et al. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 2016; 44:1910–1919.
Schaefer B, Schaefer F, Engelmann G, et al. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant 2011; 26:3633–3639.
Raina R, Grewal M, Blackford M, et al. RRT in the management of intoxications in children: recommendations from Pediatric Continuous Renal Replacement Therapy (PCRRT) Group. Ped Nephrol 2019; 34:2427–2448.
Goonasekera C, Wang J, Bunchman T, et al. Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Aphe Dial 2015; 19:16–22.
Cardoso F, Gotfried M, Tujios S, et al. US Acute Liver Failure Study Group. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology 2018; 67:711–720.
Ozanne B, Nelson J, Cousineau J, et al. Threshold for toxicity from hyperammonemia in critically ill children. J Hepatol 2012; 56:123–128.
O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445.
Devictor D, Desplanques L, Debray D, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992; 16:1156–1162.
Lu BR, Zhang S, Narkewicz MR, et al. Pediatric Acute Liver Failure Study Group. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr 2013; 162:1010.e1–1016.e4.
Bucuvalas J, Filipovich L, Yazigi N, et al. Immunophenotype predicts outcome in pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2013; 56:311–315.
Kueht ML, Cotton RT, Godfrey EL, et al. Deliberate liver transplantation for fulminant liver failure with acute lymphoblastic leukemia. Liver Transpl 2016; 22:1724–1726.
Squires JE, Rudnick DA, Hardison RM, et al. Liver transplant listing in pediatric acute liver failure: practices and participant characteristics. Hepatology 2018; 68:2338–2347.
Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652–658.
Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51:2193–2213.
Jain V, Srivastava A, Yachha SK, et al. Autoimmune acute liver failure and seronegative autoimmune liver disease in children: are they different from classical disease? Eur J Gastroenterol Hepatol 2017; 29:1408–1415.
Azhar N, Ziraldo C, Barclay D, et al. Pediatric Acute Liver Failure Study Group. Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One 2013; 8:e78202.
McKenzie RB, Berquist WE, Nadeau KC, et al. Novel protocol including liver biopsy to identify and treat CD8+ T-cell predominant acute hepatitis and liver failure. Pediatr Transplant 2014; 18:503–509.
Chapin CA, Burn T, Meijome T, et al. Indeterminate pediatric acute liver failure is uniquely characterized by a CD103+ CD8+ T-cell infiltrate. Hepatology 2018; 68:1087–1100.
Chapin CA, Melin-Aldana H, Kreiger PA, et al. Pediatric Acute Liver Failure Study Group. Activated CD8 T-cell hepatitis in children with indeterminate acute liver failure: results from a multicenter cohort. J Pediatr Gastroenterol Nutr 2020; 71:713–719.
Chapin CA, Mohammad S, Bass LM, et al. Liver biopsy can be safely performed in pediatric acute liver failure to aid in diagnosis and management. J Pediatr Gastroenterol Nutr 2018; 67:441–445.
Chapin CA, Horslen SP, Squires JE, et al. Corticosteroid therapy for indeterminate pediatric acute liver failure and aplastic anemia with acute hepatitis. J Pediatr 2019; 208:23–29.
Jain V, Dhawan A. Extracorporeal liver support systems in paediatric liver failure. J Pediatr Gastroenterol Nutr 2017; 64:855–863.
Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013; 159:522–531.
Jitraruch S, Dhawan A, Hughes RD, et al. Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure. PLoS One 2014; 9:e113609.
Dhawan A, Chaijitraruch N, Fitzpatrick E, et al. Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children. J Hepatol 2020; 72:877–884.
Alonso EM, Limbers CA, Neighbors K, et al. Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG). Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr 2010; 156:270.e1–276.e1.
Sorensen LG, Neighbors K, Zhang S, et al. Pediatric Acute Liver Failure Study Group. Neuropsychological functioning and health-related quality of life: Pediatric Acute Liver Failure Study Group results. J Pediatr Gastroenterol Nutr 2015; 60:75–83.
Sorensen LG, Neighbors K, Hardison RM, et al. Pediatric Acute Liver Failure Study Group. Health related quality of life and neurocognitive outcomes in the first year after pediatric acute liver failure. J Pediatr 2018; 196:129–138. e3.
Zamora R, Vodovotz Y, Mi Q, et al. Data-driven modeling for precision medicine in pediatric acute liver failure. Mol Med 2017; 22:821–829.
Jensen KJ, Alpini G, Glaser S. Hepatic nervous system and neurobiology of the liver. Compr Physiol 2013; 3:655–665.
Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458–462.
Cotero V, Fan Y, Tsaava T, et al. Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation. Nat Commun 2019; 10:952.